Literature DB >> 11343266

Radiofrequency ablation for hepatocellular carcinoma: help or hazard?

T Kato, K R Reddy.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11343266     DOI： 10.1053/jhep.2001.24738

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine.

Authors:  Qiong Liu; Bo Zhai; Wen Yang; Le-Xing Yu; Wei Dong; Ya-Qin He; Lei Chen; Liang Tang; Yan Lin; Dan-Dan Huang; Hong-Ping Wu; Meng-Chao Wu; He-Xin Yan; Hong-Yang Wang
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

2.  Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.

Authors:  Chung-Bao Hsieh; Hao-Ming Chang; Teng-Wei Chen; Chung-Jueng Chen; De-Chuan Chan; Jyh-Cherng Yu; Yao-Chi Liu; Tzu-Ming Chang; Kuo-Liang Shen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 3.  Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future.

Authors:  W Y Lau; Thomas W T Leung; Simon C H Yu; Stephen K W Ho
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 4.  Multimodal approaches to the treatment of hepatocellular carcinoma.

Authors:  Giuseppe Cabibbo; Federica Latteri; Michela Antonucci; Antonio Craxì
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.